Denigma cartographies changes from the molecular level to whole physiology which occur in defined contrasts such as aging and dietary as well as genetic lifespan-extending interventions:
ID | name | taxid | reference | pmid | tissue | comparision | start | stop | gender | description |
---|---|---|---|---|---|---|---|---|---|---|
107 | Rtc3 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Rtc3 levels [Herbert et al. in press]. |
106 | Hxk1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Hxk1 levels [Herbert et al. in press]. |
104 | Hsp12 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Hsp12 levels [Herbert et al. in press]. |
105 | Eno1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Eno1 levels [Herbert et al. in press]. |
108 | Rgil induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | Moderate DR upregulates Eno1 levels [Herbert et al. in press]. |
47 | Melatonin declines | 9606 | — | — | — | Age | 70/35 year | — | male/female | Melatonin peaks at night and peaks keeps dropping throughout your life and can drop by 60% by the time an individual reaches age 50. Increased age is associated with a reduction in noctronal melatonin vlaues. This drop correlates with reduction in the TAS of the blood (From Benot et al (123)). |
130 | Melatonin decreases | — | — | 18212404 | — | age | old | young | — | Melatonin level decrease with age [reviewed in 18212404]. |
128 | Accumulation of long-chain glycosphingolipids | 10090 | — | 21687659 | liver | age | 17 months | 3 months | — | Measurement of sphingolipid profiles in young (3 months), middle aged (9 moths) and old (17 months) C57BL/6 mice in liver reveals a dramatic elevations in long-chain hexosylceramides (HexCer) and lactosylceramides, with C14- and C16-lactosylcermaides (LacCers) elevated as much as 8 and 12-fold, respectively. Similar changes occur in kidney and brain [21687659]. |
127 | Accumulation of long-chain glycosphingolipids | 10090 | — | 21687659 | kidney | age | 17 month | 3 month | — | Measurement of sphingolipid profiles in young (3 months), middle aged (9 moths) and old (17 months) C57BL/6 mice in kidney reveals a dramatic elevations in long-chain hexosylceramides (HexCer) and lactosylceramides, with C14- and C16-lactosylcermaides (LacCers) elevated as much as 8 and 12-fold, respectively. Similar changes occur in liver and brain. DR prevents the decline in kidney function, inhibits the accumulation of long-chain HexCer/LacCers and and also prevents the age-associated elevation of enzymes involved in their synthesis [21687659]. |
129 | Accumulation of long-chain glycosphingolipids | 10090 | — | 21687659 | brain | age | 17 months | 3 months | — | Measurement of sphingolipid profiles in young (3 months), middle aged (9 moths) and old (17 months) C57BL/6 mice in brain reveals a dramatic elevations in long-chain hexosylceramides (HexCer) and lactosylceramides, with C14- and C16-lactosylcermaides (LacCers) elevated as much as 8 and 12-fold, respectively. Similar changes occur in kidney and liver [21687659]. |
54 | DHEA decreases | 9544 | Lane et al., 1997 | 9215277 | serum | Age | 5 year | 26 year | males/females | Males and female rhesus monkeys exhibit a steady, age-related decline in serum DHEAS. The proportional age-related loss of DHEAS in rhesus moneys is over twice the rate of decline observed in humans [9215277]. |
44 | Luteneinzing hormone increases | 9606 | Jeff | — | — | Age | 40 year | — | male and female | Luteneizing hormone increases dramatically and becomes much more bioactive after the age 40 in both mena nd women. |
61 | Loss of protein homeostasis | 6239 | — | 22103665 | whole body | — | 1 day | 11 day | hermaphrodites | Loss in protein homeostasis during aging may lead to impaird protein solubility and cellular dysfunction [22103665]. |
126 | Elevated long-chain lactosylceramides | 9606 | — | 21687659 | fibroblasts | age | old | young | — | Long-chain lactosylceramides (LacCers) are significantly elevated in human fibroblasts isolated from elderly individuals [21687659]. |
125 | Insoluble ubiquitinated proteins accumulate | 7227 | — | 18059160 | neuronal | age | old | young | — | Insoluble ubiquitinated proteins, markers of neuronal aging and degeneration, accumulate with aging in concomitantly with the age-dependent suppression of autopagy [18059160]. |
67 | Bone loss | 10090 | — | 13678781 | bone | age | 42 week | 104 week | male | In young mice the rapid growth is marked by substantial increase in bone size, mineral mass and mechanical properties. Maturation occurring between 12 and 42 weeks of age was characterized with the maintenance of bone mass and mechanical properties. From the peak levels, mice aged for 104 weeks exhibited decreased whole femur mass, percentage of mineralization diminished whole bone stiffness, energy to fracture and decreased cortical thickness. Periosteal perimeter and, consequently the cross-sectional moments of inertia continued to increase through 104 weeks, compensating for cortical thinning and increased brittleness due to decreased mineralization and stiffness. The shape of the mid-diaphysis became increasingly less elliptical in aged mice. After 52 weeks excessive endocortical resorption appeared, indicating a shift in normal mechanisms regulating bone shape and locating, suggestive of remodelling [13678781]. |
122 | Lysosomal cholesterol content decreases | 10116 | Fusheng Tang, personal communication | — | liver | age | young | old | — | In rat liver cells, the content of cholesterol in the lysosomal membrane decreases with age in spite of the overall increase of total cellular sterols. |
45 | human chorionic gonadotrophin increases | 9606 | Jeff | — | — | Age | 40 year | — | male and female | human chorionic gonadotrophin hCG increases in both men and women after age 40. |
118 | Rtc3 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Rtc3 levels [Herbert et al. in press]. |
119 | Rgi1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Rgi1 levels [Herbert et al. in press]. |
120 | Oye2 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Oye2 levels [Herbert et al. in press]. |
117 | Lys9 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Lys9 levels [Herbert et al. in press]. |
116 | Hsp31 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Hsp31 levels [Herbert et al. in press]. |
115 | Hsp26 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Hsp26 levels [Herbert et al. in press]. |
113 | Fba1 induction | 4932 | Herbert et al. in press | — | — | diet | DR (0.5% glucose) | AL (2% glucose) | — | High osmolarity upregulates Fba1 levels [Herbert et al. in press]. |
Comment on This Data Unit